Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

237
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
237
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

109
Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
109
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

135
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
135
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

135
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
135
Maxwell-Boltzmann Distribution: Problem Solving01:20

Maxwell-Boltzmann Distribution: Problem Solving

1.8K
Individual molecules in a gas move in random directions, but a gas containing numerous molecules has a predictable distribution of molecular speeds, which is known as the Maxwell-Boltzmann distribution, f(v).
This distribution function f(v) is defined by saying that the expected number N (v1,v2) of particles with speeds between v1 and v2 is given by
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigation of data-driven stopping power calibration of treatment planning x-ray CT from simulated sparse-view proton radiographies.

Physics in medicine and biology·2025
Same author

GPU-accelerated FREDopt package for simultaneous dose and LET<sub>d</sub> proton radiotherapy plan optimization via superiorization methods.

ArXiv·2025
Same author

LET spectra scoring for applications in proton radiotherapy.

Computers in biology and medicine·2025
Same author

GPU-accelerated FREDopt package for simultaneous dose and LET<sub>d</sub>proton radiotherapy plan optimization via superiorization methods.

Physics in medicine and biology·2025
Same author

A compact C-band FLASH electron linear accelerator prototype for the VHEE SAFEST project.

Frontiers in oncology·2025
Same author

In-beam PET treatment monitoring of carbon therapy patients: Results of a clinical trial at CNAO.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2024

Related Experiment Video

Updated: Sep 27, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K

A Data-Driven Fragmentation Model for Carbon Therapy GPU-Accelerated Monte-Carlo Dose Recalculation.

Micol De Simoni1,2, Giuseppe Battistoni3, Angelica De Gregorio1,2

  • 1Department of Physics, University of Rome "Sapienza", Rome, Italy.

Frontiers in Oncology
|April 11, 2022
PubMed
Summary
This summary is machine-generated.

Graphics Processing Units (GPU) accelerate Monte Carlo (MC) simulations for faster particle therapy treatment planning. The FRED software now includes a validated carbon ion model, improving accuracy and efficiency for clinical applications.

Keywords:
carbon ion (C12)fast MCfragmentationgraphics processing unit (GPU)hadrontherapyquality assurance (QA)

More Related Videos

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.9K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Related Experiment Videos

Last Updated: Sep 27, 2025

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.9K
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.9K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.5K

Area of Science:

  • Medical Physics
  • Computational Science
  • Radiation Oncology

Background:

  • Graphics Processing Units (GPU) enable faster Monte Carlo (MC) simulations compared to Central Processing Unit (CPU) hardware.
  • Rapid evaluation of particle therapy treatment plans is crucial for clinical applications.
  • FRED (Fast paRticle thErapy Dose evaluator) software utilizes GPU acceleration for ion beam treatment planning.

Purpose of the Study:

  • To present a new FRED data-driven model for carbon ion fragmentation.
  • To validate the FRED carbon ion model against the FLUKA MC software.
  • To discuss the clinical applications of FRED for 12C ion treatment planning.

Main Methods:

  • Development of a phenomenological model for carbon ion interactions based on fragmentation data.
  • Implementation of the carbon ion model within the FRED GPU-accelerated software.
  • Validation of the FRED model by comparing results with the FLUKA MC software.

Main Results:

  • The FRED software, leveraging GPU power, significantly reduces simulation time for particle therapy.
  • A new data-driven model for carbon ion fragmentation has been successfully implemented in FRED.
  • Validation tests show good agreement between the FRED carbon ion model and the FLUKA MC software.

Conclusions:

  • The updated FRED software with a carbon ion model offers a balance of accuracy and speed for treatment planning.
  • FRED serves as a valuable tool for quality assurance and research in proton and carbon ion therapy.
  • The validated FRED model facilitates clinical applications of 12C ions in treatment planning.